Telemedicine Optimized Burn Intervention (TOBI)

June 23, 2025 updated by: Medical University of South Carolina

A Novel Telemedicine Optimized Burn Intervention (TOBI) for Pediatric Burn-injured Patients and Their Caregivers

Because burn patients and their caregivers often live long distances from regional burn centers, access to expert burn care is limited, resulting in a negative effect on adherence to treatment and a higher risk of wound complication. A novel smartphone application synchronized with a web portal for providers, called the Telemedicine Optimized Burn Intervention (TOBI), was recently developed to enable burn experts to direct burn wound care while the patient and caregiver are home through text messaging, image transfer, and video-conferencing. The goal of the present study is evaluate TOBI compared to face-to-face care as usual for pediatric patients/caregivers visiting a burn center. This study will also assess the feasibility of conducting a larger-scale clinical trial in several burn centers. The app will allow the physician and patient/caregivers to make instant decisions regarding treatment, allowing for "turn on a dime" treatment decisions, rather than having the patients and families wait for scheduled clinic appointments, often hours away from home. This "on demand" medical care takes an innovative approach to increasing access to burn experts through smartphone technology and addressing adherence to prescribed treatment by increasing communication between provider and patients.

Study Overview

Study Type

Interventional

Enrollment (Actual)

130

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • South Carolina
      • Charleston, South Carolina, United States, 29425
        • Medical University of South Carolina

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 second to 18 years (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion criteria:

Caregiver parents and their children (patients) will be considered as participants and will be eligible for enrollment if:

  1. the patient (child) is < 18 years of age; caregiver age >18 years of age
  2. the patient is diagnosed with a partial thickness burn between <1% TBSA - 20% TBSA by a pediatric burn surgeon;
  3. the patient's burn is being treated with advanced burn dressing therapy (e.g., Silvadene™, Polysporin™, Acticoat™, Mepilex™, or Mepitel™);
  4. the patient's burn is evaluated by the MUSC burn team within 48 hours of injury;
  5. the patient's caregiver (parent or legal guardian) is able to speak, hear, and understand English, as determined during study recruitment procedures;
  6. the caregiver owns and is capable of using a smart device (an Android or iOS smartphone) with permission to download TOBI app from the Google Store or AppStore;
  7. able to comply with outpatient clinic visits.

Exclusion Criteria:

  • There are no exclusion criteria. All participants who meet inclusion criteria would be eligible to participate in the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Face-to-face arm
Standard face-to-face burn care.
If the participants are assigned to FTF care, they will receive standard burn care including a return follow-up in the burn clinic on a routine basis as prescribed by the clinical burn team (at least once per week) until the burn has healed.
Experimental: TOBI arm
A novel smartphone application for burn wound care, called the Telemedicine Optimized Burn Intervention (TOBI), was recently developed to enable burn experts to direct burn wound care while the patient and caregiver are home through text messaging and video-conferencing. The app was designed to bring expert wound care directly to the patient's home to address barriers to healthcare, including high cost burden and time commitment (e.g., geographic limitations, transportation to burn centers, parking, lodging, meals, time away from school and work), particularly for patients/families in rural and medically underserved communities. TOBI is synced with a portal used by providers, as an adjunct to standard therapy. This burn app provides education through frequently asked questions, instructional burn dressing change videos in addition to direct communication between patient and burn expert through store-and-forward pictures and videoconferencing.
Participants assigned to TOBI will be given instructions how to download and use TOBI on a smartphone, including how to interface with burn clinicians using text-messaging, videoconferencing, and sending photos of the child's burn(s). The participants will have scheduled video visits with the care provider at least weekly until the burn has healed. The participants will be able to use other features of the app, such as text-messaging and sending photos of the burn(s), as needed. The participants will be able to use standard FTF burn care as well. They will be given instructions how to contact the burn team through the hospital paging operator if TOBI is unavailable or there is an emergency.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of Participants Who Agree to Participate in the Study
Time Frame: At enrollment
Looking at the number of participants (parents and children) who agree to enroll in the study at the time of burn injury versus the total number of participants who were approached to participate in the study.
At enrollment
Number of Participants Retained in the Study Over Time
Time Frame: From enrollment to 30 days after burn wound has healed (up to 35 days after enrollment).
Looking at the number of participants retained in the study versus those lost to attrition
From enrollment to 30 days after burn wound has healed (up to 35 days after enrollment).
Wound Care Treatment Adherence
Time Frame: Assessed weekly at clinic/telemedicine visit until burn wound was healed, up to 35 days after injury
Looking at the percentage of patient/caregiver dyads who adhered to prescribed burn wound care treatment protocol. A wound care fidelity checklist was used at each visit to determine the percentage of wound care adherence per visit. These percentages were then averaged for each weekly visit to give the value below.
Assessed weekly at clinic/telemedicine visit until burn wound was healed, up to 35 days after injury
Number of Child Participants That Experienced Adverse Events, Serious Adverse Events, and Unexpected Problems
Time Frame: Assessed weekly until burn wound was healed, up to 35 days
Looking at the number of child participants in each condition that experienced adverse events, serious adverse events, and unexpected problems. Adverse events in this study included infection, delay in wound care or non-healing wound. Adult caregivers are not included in this as they did not have burn wounds that were assesssed.
Assessed weekly until burn wound was healed, up to 35 days
Number of Times Problems With Technology Happened in the TOBI Condition
Time Frame: Assessed weekly until burn wound was healed, up to 35 days
Looking at the number of times providers or participants experienced and reported technological problems with TOBI
Assessed weekly until burn wound was healed, up to 35 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Attitudes Towards Technology and Telemedicine Questionnaire
Time Frame: Measured at baseline and 1-month follow-up
Looking at the change in group average scores on the Attitudes Towards Technology and Telemedicine Questionnaire (caregiver-reported) from baseline to 1 month follow-up. Scores may range between 26-130, with higher scores = more positive attitudes towards technology and telemedicine.
Measured at baseline and 1-month follow-up
Perception of Healthcare Access
Time Frame: Measured at baseline and 1-month follow-up
Looking at the change in group average scores on the Barriers to Care Questionnaire (BCQ), Pragmatics Subscale (caregiver-reported). Scores range from 0-100, with higher scores = fewer barriers and problems with access.
Measured at baseline and 1-month follow-up
Number of Days Until Wound is Healed
Time Frame: Measured during the treatment phase (2-4 weeks)
Looking at the number of days it takes for wound to heal following burn injury in both conditions
Measured during the treatment phase (2-4 weeks)
Number of Unscheduled ED or Clinic Visits
Time Frame: Measured during the treatment phase (2-4 weeks)
Looking at the number of times participants had unscheduled visits (in the ED or the clinic)
Measured during the treatment phase (2-4 weeks)
Number of Wound Complications
Time Frame: Measured during the treatment phase (2-4 weeks)
Looking at the number of wound complications (e.g., infection, conversion to deeper burn requiring surgery, conversion to deeper burn requiring a change in therapy).
Measured during the treatment phase (2-4 weeks)
Patient-reported Pain Scores
Time Frame: Measured during the treatment phase (week 1 clinic visit)
Looking at average pain score at follow up visits between the two groups using the Wong-Baker Scale (0-10, with higher scores = more pain). Most patients only attended one follow up visit but if more than one, the average score is reported below.
Measured during the treatment phase (week 1 clinic visit)
Caregiver's Perception of Child's Pain Scores
Time Frame: Measured during the treatment phase (week 1 clinic visit)
Looking at average caregiver's perception of child's pain score at follow up visits between the two groups using the Wong-Baker Scale (0-10, with higher scores = more pain). Most dyads only attended one follow up visit but if more than one, the average score is reported below.
Measured during the treatment phase (week 1 clinic visit)
Positive And Negative Affect Schedule (PANAS) Scores
Time Frame: Measured at baseline/enrollment and 1-month follow-up.
Looking at the group average scores on the PANAS questionnaire measuring positive and negative affect (caregiver-reported). The means of the positive and negative scores for PANAS are reported below along with standard deviations. The scores range between 10-50, with higher scores = higher levels of affect (both positive and negative). For positive affect, a higher score is a better outcome and for negative affect, a lower score is a better outcome. Scores are reported for baseline and 1 month after burn wound healing.
Measured at baseline/enrollment and 1-month follow-up.
Patient-Reported Outcomes Measurement Information System - Depression (PROMIS-Depression) Scores
Time Frame: Measured at baseline and 1-month follow-up
Looking at the baseline and 1-month follow up scores on the Patient-Reported Outcomes Measurement Information System (PROMIS)-Depression questionnaire (caregiver-reported). Each item on the measure is rated on a 5-point scale (1=never; 2=rarely; 3=sometimes; 4=often; and 5=always) with a range in score from 8 to 40 with higher scores indicating greater severity of depression. The raw scores on the 8 items should be summed to obtain a total raw score. Next, the T-score table is used to identify the T-score associated with the individual's total raw score. The mean T-scores is 50 with a standard deviation of 10. T-scores range between 37.1-81.1. T scores are interpreted as follows: <55 (none to slight depression), 55-59.9 (mild depression), 60-69.9 (moderate depression), >70 (severe depression). T scores and standard error are reported below.
Measured at baseline and 1-month follow-up
Patient-Reported Outcomes Measurement Information System - Anxiety (PROMIS-Anxiety) Scores
Time Frame: Measured at baseline and 1-month follow-up
Looking at the baseline and 1-month follow up scores on the Patient-Reported Outcomes Measurement Information System (PROMIS)-Anxiety questionnaire (caregiver-reported). Each item on the measure is rated on a 5-point scale (1=never; 2=rarely; 3=sometimes; 4=often; and 5=always) range in score from 7 to 35 with higher scores indicating greater severity of anxiety. The raw scores on the 7 items should be summed to obtain a total raw score. Next, the T-score table is used to identify the T-score associated with the individual's total raw score. The mean T-scores is 50 with a standard deviation of 10. T-scores range between 36.3-82.7. T scores are interpreted as follows: <55 (none to slight anxiety), 55-59.9 (mild anxiety), 60-69.9 (moderate anxiety), >70 (severe anxiety). T scores and standard error are reported below.
Measured at baseline and 1-month follow-up
Patient-Reported Outcomes Measurement Information System - General Self-Efficacy (PROMIS-General-Self-Efficacy) Scores
Time Frame: Measured at baseline only
Looking at the baseline and 1-month follow up scores on the Patient-Reported Outcomes Measurement Information System (PROMIS)-General Self Efficacy questionnaire (caregiver-reported). Each item on the measure is rated on a 5-point scale (1=never; 2=rarely; 3=sometimes; 4=often; and 5=always) range in score from 8 to 40 with higher scores indicating greater self efficacy. The raw scores on the 7 items should be summed to obtain a total raw score. Next, the T-score table is used to identify the T-score associated with the individual's total raw score. The mean T-scores is 50 with a standard deviation of 10. T-scores range between 22.72-64.98. A T-score value of 55 indicated that the respondent has greater self-efficacy for managing emotions. Higher scores indicating more self efficacy and lower scores with less self efficacy. T scores and standard error are reported below.
Measured at baseline only
Patient-Reported Outcomes Measurement Information System - Self-Efficacy to Manage Emotions (PROMIS-Self-Efficacy-Manage-Emotions) Scores
Time Frame: Measured at baseline only
Looking at the baseline and 1-month follow up scores on the Patient-Reported Outcomes Measurement Information System (PROMIS)-Self-Efficacy Managing emotions questionnaire (caregiver-reported). Each item on the measure is rated on a 5-point scale (1=never; 2=rarely; 3=sometimes; 4=often; and 5=always) range in score from 4-20 with higher scores indicating greater severity of anxiety. The raw scores on the 4 items should be summed to obtain a total raw score. Next, the T-score table is used to identify the T-score associated with the individual's total raw score. The mean T-scores is 50 with a standard deviation of 10. T-scores range between 36.3-82.7. A T-score of 55 and greater indicates that the respondent has greater self efficacy and ability to manage their emotions regarding disease. A higher score than 55 indicates even more self efficacy and lower score, less. T scores and standard error are reported below.
Measured at baseline only
Peritraumatic Distress Inventory (PDI) Sores
Time Frame: Measured at baseline only
Looking at average scores on the Peritraumatic Distress Inventory (caregiver-reported). Scores range between 0-52, with higher scores = greater peritraumatic distress. An optimal cutoff score of 23 (sensitivity = 71%; specificity = 73%) is good for predicting clinically elevated PTSD 30-days post-injury.
Measured at baseline only
Perceived Stress Scale (PSS) Scores
Time Frame: Measured at 1-month follow-up only
Looking at average scores on the Perceived Stress Scale (caregiver-reported) between two conditions. Scores on the PSS can range from 0 to 40 with higher scores = higher perceived stress. Scores ranging from 0-13 would be considered low stress. Scores ranging from 14-26 would be considered moderate stress. Scores ranging from 27-40 would be considered high perceived stress.
Measured at 1-month follow-up only
Posttraumatic Growth Inventory (PTGI) Scores
Time Frame: Measured at 1-month follow-up only
Average scores on the Posttraumatic Growth Inventory (caregiver-reported). Scores range from 0-105, with higher scores = greater posttraumatic growth.
Measured at 1-month follow-up only
Client Satisfaction Questionnaire-8 (CSQ-8) Scores
Time Frame: Measured at 1-month follow-up only
Looking at average scores on the Client Satisfaction Questionnaire-8 scores (caregiver-reported). Scores range between 8-32, with higher scores = greater satisfaction.
Measured at 1-month follow-up only
mHealth App Usability Questionnaire (MAUQ) Scores
Time Frame: Measured at 1-month follow-up only
Looking at average scores on the MAUQ questionnaire measuring app usability (caregiver-reported in TOBI condition only). Raw scores range between 21-147 and average scores range between 1-7, with higher overall score equivalent to higher usability of the app. The average scores and standard deviation are reported below for the TOBI group.
Measured at 1-month follow-up only
Total Number of Face-to-face Visits
Time Frame: Treatment phase (weeks 2-4)
Looking at the total number of face-to-face visits
Treatment phase (weeks 2-4)
Total Number of TOBI Visits
Time Frame: Treatment phase (weeks 2-4)
Looking at the total number of TOBI visits
Treatment phase (weeks 2-4)
Total Travel Time
Time Frame: From enrollment through treatment phase (weeks 1-4)
Looking at the total travel time in each condition as reported by the caregiver.
From enrollment through treatment phase (weeks 1-4)
Direct Cost to Patient/Caregiver
Time Frame: From enrollment through treatment phase (weeks 1-4)
Looking at the direct cost to patient/caregiver as reported by caregiver
From enrollment through treatment phase (weeks 1-4)
Time to Return to Work
Time Frame: From enrollment through the treatment phase (weeks 1-4). This included any time that the parent had was out of work because of the injury at time of occurrence or due to clinic follow up.
Looking at the average time it took patient/caregiver to return to work after burn wound injury.
From enrollment through the treatment phase (weeks 1-4). This included any time that the parent had was out of work because of the injury at time of occurrence or due to clinic follow up.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2022

Primary Completion (Actual)

March 8, 2024

Study Completion (Actual)

March 8, 2024

Study Registration Dates

First Submitted

August 18, 2021

First Submitted That Met QC Criteria

August 18, 2021

First Posted (Actual)

August 24, 2021

Study Record Updates

Last Update Posted (Actual)

July 11, 2025

Last Update Submitted That Met QC Criteria

June 23, 2025

Last Verified

June 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Pro00109037
  • K23HD098328-01A1 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Burns

Clinical Trials on Face-to-face burn care

Subscribe